Andrew Doyle

Haematologist (GSTT) - Research Fellow (KCL) - Northerner in the Big City - Runner - Relapsed Caffeine Addict

[HaemSTAR 💙 @HaemSTAR_UK]

Survey for #haematology consultants! If you manage/give advice for the management of PE in pregnancy, we want to hear from you. Please take part in this short survey and help us build better evidence for women! 🤰 https://t.co/9estx56AG9

[Andrew Doyle @doyley1_]

@KarenS_LDN @AtrialHypati @Christine_ga_ @bhwords @SavinoSciascia Congratulations! Very exciting news #APS

[Andrew Doyle @doyley1_]

@DrBenLovell More importantly, how do you make this? Sounds like an episode of the Apprentice gone wrong

[Andrew Doyle @doyley1_]

Relapse data for TTP from the UK TTP registry finally out #TTP #rituximab @UKTTPRegistry @TTP_Network https://t.co/HEg6oecE5e

[Andrew Doyle @doyley1_]

Best way to get to a conference? #ISTH2022

[Andrew Doyle @doyley1_]

@LaraNRoberts1 @bhwords @isth @thrombosisday Please don't encourage @bhwords

[Andrew Doyle @doyley1_]

It's been dusted off ready for this weekend! @bhwords @isth @thrombosisday #clotsuit #ISTH2022

[Andrew Doyle @doyley1_]

Celebrating our team's diversity with traditional dishes from their cultural background @GSTTnhs #haemteam #DiversityandInclusion

[HaemSTAR 💙 @HaemSTAR_UK]

Hurrah!!!
We've launched the 2022 Flash Mob Project 'RAPIDO'
We're auditing the use of reversal agents for DOACs across the UK - 23 centres signed up so far. Don't miss out on being part of something powerful!
More info: https://t.co/oGsc4TVIOS, DM, or [email protected]

[HaemSTAR 💙 @HaemSTAR_UK]

Do you have an audit or research project idea in classical haematology (gen haem, H&T, transfusion)? If so, get in touch with us and let's try and make it happen! All contact info at https://t.co/51khxQlRYY

[HaemSTAR 💙 @HaemSTAR_UK]

1/6
YESSSS!!!
Our second ever Flash Mob project is now published and is Open Access in @JTHjournal. In the largest ever, multicentre study of time to treatment in #TTP we found that diagnostic uncertainty was the most frequent reason for treatment delay. https://t.co/TNAkGe4pzN

[Andrew Doyle @doyley1_]

@richardbuka Congratulations

[Andrew Doyle @doyley1_]

@APSsupportUK Useful tweet - demonstrates the increasing complexity in deciding which is the best anticoagulant for patients with APS in the long-term

[Andrew Doyle @doyley1_]

Ecstatic with my result (2 hrs 48 mins) Amazing crowd support! Thank you everyone for coming to cheers @LondonMarathon @LDNFrontrunners

[Andrew Doyle @doyley1_]

Kit ready for @LondonMarathon 2021. Nerves have set in!

[Andrew Doyle @doyley1_]

Great news! Hopefully a game changer for IVIg use in UK with lessons learnt from the past about plasma products. Current access schemes do make you think about the dosing & utility of what you prescribe - would be sensible to continue @NHSBT #haematology

https://t.co/cXy0j0JQY5

[Dr. Glaucomflecken @DGlaucomflecken]

Hanging out with the hematologist

[Andrew Doyle @doyley1_]

GMC: Medical schools must include BAME representation in clinical teaching - Sign the Petition! https://t.co/IGOymaGNDj via @UKChange

[Andrew Doyle @doyley1_]

@NicoleRelke @bhwords @sholzberg @NicholasJC95 Agreed - really useful

[Professor Beverley Hunt OBE (also on BlueSky) @bhwords]

DOAC use in APS & unprovoked VTE: our centre experience
- 85% pts did not want to switch back to warfarin after counselling re MHRA & EMA warning
- low risk of recurrent VTE on DOACs in this small group
@doyley1⁦@doyley1_⁩
⁦@karenbr001⁩ https://t.co/taEBIn8nbQ